Psoriasis imposes a high quality-of-life burden, with patients reporting transportation barriers and difficulties accessing medication.

The CDC found that patients in the US were less likely to contract a health care-associated infection in 2023 than in 2015.

Topical timolol 1% is effective and well-tolerated in children aged 1 to 5 years with persistent IH, with regression reported in 69.03% of children.

A phenotype-based approach to CaHA use in facial rejuvenation treatments was associated with greater improvements across various aesthetic scales.

Among patients with cancer, 53% reported interest in patient navigation services, including financial and legal services.

Individuals with vitiligo have an overall reduced risk of developing skin cancer, according to a recently published cohort study.

Despite high OS rates in patients with resectable stage III melanoma, recurrence is common at 36 months of treatment with immunotherapy.

High levels of daytime light exposure is linked to reduced dementia risk, and risk is further reduced with longer exposure to brighter light.

A 70-year-old man with a past medical history of hypertension presents with a changing lesion and a complaint of a mole on his upper arm.

Biologic exposure for psoriasis is not associated with an increased rate of adverse pregnancy outcomes when compared with biologic-naïve patients.

Substantial proportions of 8th-, 10th-, and 12th-grade students fail to attribute great risk to experimental or occasional fentanyl use.

While no association was observed between use of biologics and incident PsA overall, specific biologic classes were associated with reduced risk.